Brief: In8bio’S Announces Publication Of Preclinical Results In Mouse Models Of Glioblastoma Multiforme
27/10/2021 13:44
Oct 27 (Reuters) - IN8BIO, Inc. INAB.O :
* IN8BIO’S ANNOUNCES PEER-REVIEWED PUBLICATION OF
PRECLINICAL
RESULTS USING PROPRIETARY MGMT-MODIFIED GAMMA-DELTA T CELLS
(INB-200) WITH TEMOZOLOMIDE IN MOUSE MODELS OF GLIOBLASTOMA
MULTIFORME
Source text for Eikon: ID:nGNX6pVYt3
Further company coverage: INAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IN8bio
See all newsIN8bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Biopharma firm IN8bio's Q2 net loss narrows as expenses decline
IN8bio Inc expected to post a loss of 37 cents a share - Earnings Preview
Brief: IN8BIO - Enters Capital On Demand Sales Agreement With Jonestrading For ATM Offering
IN8bio Q1 net loss narrows as R&D expenses fall